Cogentin

Benztropine A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine.

Molecular Formula: C₂₂H₂₉NO₄S

InChI: InChI=1/C21H25NO.CH4O3S/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17;1-5(2,3)4/h2-11,18-21H,12-15H2,1H3;1H3,(H,2,3,4)/t18-,19-;/m1./s1/f/h;2H

InChIKey: InChIKey=CPFJLLXFNPCTDW-SEMYEPHVDS
SMILES: CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O

Names:
    Benzatropine methanesulfonate
    Benzotropine mesylate
    Benzotropine methanesulfonate
    Benztropine mesilate
    BENZTROPINE MESYLATE
    Benztropine methanesulfonate
    Cobrentin methanesulfonate
    Cogentin
    MK 02
    (1R,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane; methanesulfonic acid
    3-Diphenylmethoxytropane mesylate

Registries:
    PubChem CID 8584
    PubChem ID 151740